We’re excited to welcome Dr. Michael Hayden for an open conversation on biotech innovation, from building successful companies and exits to tackling today’s biggest challenges and exploring Israel’s role in the global biotech scene.
From 2012 to 2017, Dr. Hayden served as President of Global R&D and Chief Scientific Officer at Teva, and currently serves as the CEO of Prilenia Therapeutics as well as a Killam Professor at the University of British Columbia. Over his career, he has co-founded five biotech companies: NeuroVir, Xenon, Aspreva, 89bio, and Prilenia, and serves on multiple boards of both public and private biotech companies.
Come listen, ask questions, and join an open discussion with a visionary scientist and entrepreneur shaping the future of life sciences.
We’d love to hear from you! What topics or questions would you like to explore during the session?
Kick off with light refreshments and informal networking.
Welcome by Daniel Rabina, AWS, joining the Pharma Tech Forum.
Open conversation on biotech, entrepreneurship, and the road from science to impact.
Interactive discussion with Dr. Hayden.
Wrap up the with relaxed networking among founders, researchers, and industry experts.

Co-founder & CTO
Scala Biodesign

Senior Data Scientist
NVIDIA

CTO
PhaseV

Co-founder and CTO
Protai Bio

VP of Ideation and Scouting
AION Labs

Head of AI
Quris AI
From tackling industry challenges to sharing knowledge and providing actionable tools, we bring together key players including founders, investors, researchers, technologists, and ecosystem enablers to foster the next wave of innovative companies.
Whether you’re looking to connect with industry leaders, gain insights from sector-specific discussions, or engage with potential partners, this forum is your gateway to the next wave of bold and determined Pharma Tech innovation.
Registration for this event is now closed.
You’ll receive a confirmation email shortly with a calendar invite. Stay tuned!